Genocea Biosciences, Inc., a Cambridge, Massachusetts-based, clinical-stage vaccine developer, announced a new appointment on Monday to the position of chairman of the board. (NASDAQ:GNCA) is a clinical-stage biotechnology firm, engaged in the discovery and development of vaccines for infectious diseases, for which there are no extant vaccines, or vaccines with limited effectiveness. The oral presentation, titled “Therapeutic HSV-2 Vaccine (GEN-003) Results in Durable Reduction in Genital Lesions at 1 Year “, will be… Anna Wald, the Principal Investigator on the study, will present the detailed interim data during a session on Vaccine Development and Efficacy on September 12 in Denver, Colorado.”We are pleased that ICAAC has chosen to accept our abstract given the limited number of late-breaking submissions that are selected, and believe that this acceptance reflects the quality of the study to be presented and the need for new therapeutic approaches to the HSV-2 epidemic,” said Chip Clark, President and Chief Executive Officer of Genocea.The following abstract will be presented: Presentation number G-1458a, “Novel Therapeutic Vaccine for Genital Herpes Reduces Genital HSV-2 Shedding,” 3:00 – 5:30 p.m. About GEN-003 GEN-003 is a first-in-class, protein subunit, therapeutic T cell vaccine intended to reduce recurrence and transmission of Herpes Simplex Virus type 2 (HSV-2). “We are pleased that ICAAC has chosen to accept our abstract given the limited number of late-breaking submissions that are selected, and believe that this acceptance reflects the quality of the study to be presented and the need for new therapeutic approaches to the HSV-2 epidemic,” said Chip Clark, President and Chief Executive Officer of Genocea. Genocea is currently enrolling a Phase 1/2a study of GEN-003 and expects to report preliminary data in the second half of 2013.
Patients received three injections of the assigned treatment into an arm muscle at 21 day intervals, and were followed for 12 months after the third injection. It’s also important to realize that sexually transmitted infections can have similar symptoms as UTIs guys. I have had them 4 times life. “Although the ultimate goal of this vaccine is reducing genital herpes outbreaks and reducing transmission of the virus to others, this is only the first step on a long path toward reaching that goal. Your life continue normal, as time goes by, OB tend to be milder and short. Prior to Wyeth, George was director of the Massachusetts Public Health Biologic Laboratories and a Harvard Medical School Associate Professor of Medicine at Dana Farber Cancer Institute. There is no licensed vaccine to prevent malaria, an infection caused by Plasmodium parasites transmitted by mosquitoes.
alone, an estimated 50-60 million people are affected. and key European markets. During these times, HSV be transmitted tratamiento para herpes solar partners. We would to know about anti herpes simplex ii igg the comments. coli/cLLO/OVA, which can be either alive or paraformaldehyde fixed. Herpes Dating Pictures Personals for single people with Herpes and other Sexually Transmitted Diseases . And investments created more than 106,000 jobs, the center said.